Diazocine derivatives and their use as tryptase inhibitors

Details for Australian Patent Application No. 2002238522 (hide)

International Classifications

Event Publications

20 February 2003 Application Open to Public Inspection

Published as AU-B-2002238522

27 November 2003 Change of Name(s) of Applicant(s), Section 104

BYK Gulden Lomberg Chemische Fabrik GmbH. The name of the applicant has been changed to Altana Pharma AG

21 December 2006 Application Accepted

Published as AU-B-2002238522

18 January 2007 Corrigenda

Applications Accepted - Name Index Under the name ALTANA Pharma AG, Application No. 2002238522, under INID (72), correct the co-inventor to Stadlwieser, Josef

19 April 2007 Standard Patent Sealed

20 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.